Cover Image

Learning Curve of Botulinum Toxin Bladder Injection for the Treatment of Refractory Overactive Bladder

Marta Barba,1 Tetyana Lazar,1 Alice Cola,1 Giuseppe Marino,1 Stefano Manodoro,2 Matteo Frigerio3 1University Milano-Bicocca, San Gerardo Hospital, Monza, Italy; 2ASST Santi Paolo e Carlo, San Paolo Hospital, Milano, Italy; 3ASST Monza, San Gerardo Hospital, Monza, ItalyCorrespondence: Marta BarbaUni...

Full description

Saved in:

Bibliographic Details
Main Authors:	Barba M (Author), Lazar T (Author), Cola A (Author), Marino G (Author), Manodoro S (Author), Frigerio M (Author)
Format:	Book
Published:	Dove Medical Press, 2022-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The application of botulinum toxin in the treatment of overactive bladder
by: Justyna Wojcik, et al.
Published: (2020)

Mirabegron in Overactive Bladder and Its Role in Exit Strategy After Botulinum Toxin Treatment in Children
by: Denise Jia Yun Tan, et al.
Published: (2022)

Overactive bladder
by: Anna Zwierzyńska
Published: (2021)

Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder
by: Qin-Qin Gong, et al.
Published: (2020)

Hengli® Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
by: Limin Liao, et al.
Published: (2022)

The Experimental overactive bladder modelling
by: O. I. Iatsyna, et al.
Published: (2018)

The Experimental overactive bladder modelling
by: O. I. Iatsyna, et al.
Published: (2018)

Clinical Efficacy of Transurethral Resection of the Prostate Combined with Oral Anticholinergics or Botulinum Toxin – A Injection to Treat Benign Prostatic Hyperplasia with Overactive Bladder: A Case–Control Study
by: Allameh F, et al.
Published: (2020)

OVERACTIVE BLADDER SYNDROME IN CHILDREN
by: E.L. Vishnevskiy
Published: (2007)

OVERACTIVE BLADDER SYNDROME IN CHILDREN
by: E.L. Vishnevskiy
Published: (2007)

Mirabegron in the Management of Overactive Bladder Syndrome
by: O'Kane M, et al.
Published: (2022)

The Association of Bladder Wall Thickness with Severity of Symptoms in Patients with Overactive Bladder
by: Ronny Adrian, et al.
Published: (2017)

Fesoterodine for the treatment of urinary incontinence and overactive bladder
by: Pamela Ellsworth
Published: (2009)

Chapter Biomarkers in the Overactive Bladder Syndrome
by: Silva, Carlos
Published: (2012)

Chapter Biomarkers in the Overactive Bladder Syndrome
by: Silva, Carlos
Published: (2012)

New in the diagnosis of overactive bladder (review)
by: F N Mahmedzhanova, et al.
Published: (2013)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
by: Stacey Tannenbaum, et al.
Published: (2020)

An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder
by: Frankel J, et al.
Published: (2022)

Profile of mirabegron in the treatment of overactive bladder: place in therapy
by: Sharaf A, et al.
Published: (2017)

Overactive bladder: An underestimated troublesome problem in women
by: Yiu-Tai Li, et al.
Published: (2022)

The overactive bladder model anatomical and morphological correlates
by: O. I. Iatsyna
Published: (2018)

The overactive bladder model anatomical and morphological correlates
by: O. I. Iatsyna
Published: (2018)

Pharmacoeconomic feasibility of using Mirabegron in patients with overactive bladder
by: I. N. Dyakov, et al.
Published: (2021)

The Association Between Urinary Tract Infection and Overactive Bladder Treatment
by: Kuang-Ming Liao, et al.
Published: (2022)

Intracavitary electrical stimulation as treatment for overactive bladder: systematic review
by: Rafaela Fintelman Rodrigues, et al.

Overactive bladder (OAB) in women: questionnaire based approach
by: Veena Ganju Malla, et al.
Published: (2020)

Clinical and urodynamic effects of tolterodine in women with an overactive bladder
by: Chiu-Lin Wang, et al.
Published: (2013)

Literature Review: Quality of Life in Patients with Overactive Bladder
by: Vitaria Wahyu Astuti, et al.
Published: (2022)

Clinical Correlation Between Overactive Bladder and Allergy in Children
by: Lu Yin, et al.
Published: (2022)

Medicinal plants and natural products for treating overactive bladder
by: Huanxian Chen, et al.
Published: (2024)

Adherence to Overactive Bladder Syndrome Treatments Recent Developments and Future Perspectives
by: Robinson D, et al.
Published: (2023)

Botulinum toxin treatment of refractory vaginismus: a prospective study
by: Sejal Ajmera Desai, MD, et al.
Published: (2024)

Hyper-dilute botulinum toxin as an effective treatment for refractory erythromelalgia
by: Ariel Brown, BA, et al.
Published: (2024)

Ultrasound-assisted intravesical botulinum toxin A delivery attenuates acetic acid-induced bladder hyperactivity in rats
by: Qinggang Liu, et al.
Published: (2023)

Oxybutynin and tolterodine in a trial for treatment of overactive bladder in Iranian women.
by: Elham Aziminekoo, et al.
Published: (2014)

Pathogenesis of overactive bladder and surgical treatment according to the Integral Theory Paradigm
by: Peter Petros
Published: (2021)

Mirabegron and Anticholinergics in the Treatment of Overactive Bladder Syndrome: A Meta-analysis
by: Luisa Gracio Ferreira Sartori, et al.
Published: (2023)

Mirabegron: pharmacoeconomic aspects of the use of the drug for the treatment of overactive bladder syndrome
by: O. I. Ivakhnenko, et al.
Published: (2022)

Evaluation of quality of life in women with overactive bladder (a survey)
by: F N Makhmejanova
Published: (2014)

Relationship between anxiety and overactive bladder syndrome in older women
by: Aline Teixeira Alves, et al.
Published: (2014)